Other appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.
|
|
- Gervase White
- 5 years ago
- Views:
Transcription
1 Executive Committee Guido Oelkers Chief Executive Officer Born Employed since PhD in Strategic Management, University of South Australia, Master of Economics, South Bank University, London, Complementary studies in Economics, London School of Economics and Political Science. Other appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT. Previous positions: CEO BSN Medical, President & CEO Gambro, EVP Commercial Operations Nycomed, CEO Invida, Global Head of Healthcare DKSH, previous managerial roles at Aventis and preceding entities, member of the Board of Directors at Meda and Sartories AG. Henrik Stenqvist Chief Financial Officer Born Employed since Degree in Finance and Business Administration from the University of Linköping, Sweden. Previous positions: CFO Recipharm , CFO Meda, , CFO
2 Pharmalink, , Regional Finance Director Astra Zeneca , Finance Director Astra Export&Trading, , Financial Manager, Astra Hungary, Torbjörn Hallberg General Counsel and Head of Legal Affairs Born Employed since Master of Laws from the University of Lund, Sweden. Previous positions: Vice President, General Counsel, Emerging Markets at Takeda Pharmaceuticals Senior Director and Senior Corporate Counsel, Takeda Pharmaceuticals, , Corporate Councel, Nycomed Pharma, , Corporate Councel, Ferring Pharmaceuticals, , Senior Associate/Lawer at Advokatfirman Lindahl, Hege Hellström Head of EMENAR Born Employed since Bachelor in Bioengineering Previous positions: Global head of Cardiovascular business unit in Sanofi, Vice President Renal Europe and Head of Regional Liaisons, Sanofi, Vice President Renal and Endocrine Europe, Genzyme, General Manager Benelux Genzyme. Prior to Genzyme 13 years in Baxter.
3 Anne Marie de Jonge Schuermans Head of Technical Operations Born: Employed since PhD from Swiss Federal Institute of Technology Zurich (ETHZ); M.Sc. degrees in Agriculture & Natural Environment from Wageningen Agricultural University in the Netherlands and in Environmental Management & Technology from the Ecole Polytechnique Féderale Lausanne (EPFL) in Switzerland. Previous positions: Biogen, Vice President for Global Supply Chain Operations & Strategic Partnerships, and Executive Board Member of Biogen International GmbH; more than 15 years of experience in the healthcare industry from Biogen, Stryker and Novartis, where she headed international functions including Supply Chain Operations, Internal & External Manufacturing, Quality, EHS (Environment, Health & Safety) and Healthcare Compliance. Rami Levin Head of North America Born Employed since MBA from Rekanati Business School, Tel-Aviv University, Israel. BSc in Biology - Tel-Aviv University, Israel. Other appointments: Board of advisors of "Life Science Cares", Corporate alliance member for Global Genes, Corporate council member for the National Organization for Rare Disorders (NORD), Regional chamber representative for the Swedish
4 American Chamber of Commerce. Previous positions: Various senior roles within Merck since 1998, most recently as Vice President of Marketing (US). Managing Director Scandinavia, Global Marketing Head, Business Unit Manager. Product Manager, Schering AG. Norbert Oppitz Head of Specialty Care Born Employed since Dipl. BW (FH)/Business Administrator, FH Rhenania Palatina/Mainz, Germany Previous positions: Member of the Executive Committee of BSN Medical in charge of Latin America. Member of the Executive Committee of Endo Pharmaceuticals, Emerging Markets. Head of Latin America, Takeda/Nycomed as well as country management roles at Roche Pharmaceuticals and Aventis Pharma. Armin Reininger Head of Medical and Scientific Affairs Born Employed since MD, PhD, Ludwig-Maximilians-University Munich, Germany; certified specialist in Transfusion Medicine Previous positions: Baxter Head of Medical Affairs EMEA Hemophilia, Baxalta Head of Global Medical Affairs Hematology, Baxalta/Shire Head of Medical Affairs EMEA Hematology, Senior Physician University Clinic Munich, Dpt. of Transfusion Medicine and Haemostaseology. Visiting Scientist-Visiting Lecturer Harvard Medical School, Mass. General Hospital, Boston, MA, Visiting Fellow The Scripps Research Institute, La Jolla, CA, Professor of Anatomy at the Ludwig Maximilians-University Munich,
5 Germany. Fredrik Wetterlundh Head of Human Resources Born Employed since Holds a degree in HR Management from the University of Lund, Sweden. Previous positions: Global Human Resources Lead at Pfizer. Senior HR roles in Astra Zeneca, Kraft Foods as well as Codan Group. Philip Wood Head of Haemophilia Born Employed since 2012 BSc Joint Honours degree in Geology and Physical Geography, Charted Institute of Marketing certification. Previous appointments: Head of European Strategic Asset team, Haemophilia, and Business Unit Head Haemophilia, UK, Pfizer. Milan Zdravkovic
6 Head of Research & Development, Chief Medical Officer Born: Employed since: 2016 MD, PhD University of Aarhus, Denmark, MSc Pharmaceutical Medicine, University of Surrey, United Kingdom Other appointments: DIA Advisory Council Europe, Middle East and Africa. Board member and co-founder of Selma Diagnostics Aps Previous positions: Corporate Vice President, Novo Nordisk. 18 year tenure in the Research and Development organisation at Novo Nordisk responsible for therapeutic areas including diabetes, devices, growth hormone deficiency, obesity and immunology. Experience from early stage drug development to post-approval life-cycle management.
Born Ph.D. from Karolinska Institutet in Stockholm. Board member since 2016.
Board of Directors Håkan Björklund Chairman Born 1956. Ph.D. from Karolinska Institutet in Stockholm. Board member since 2016. Other appointments: Currently serves as Industry Executive at Avista Capital
More informationPROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium
PROTECT Project Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium Content of Presentation About IAPO Overview of PROTECT Work Package 4 - New methods for data
More informationExecutive Management FREDRIK RÅGMARK. Executive Management - Medicover Medicover
Executive Management - Medicover Medicover Executive Management FREDRIK RÅGMARK CEO Born 1963 Employed at Medicover since 1996 Board member since 1997 Nationality: Swedish Other current assignements Law
More informationCorporate Compliance & Transparency
4 th Annual Conference Corporate Compliance & Transparency in the Pharmaceutical Industry 24 25 February 2016 Zürich, Switzerland Conference In Numbers 84 Attendees 2 Days 29 Speakers 19 Participating
More informationNOTICE OF ANNUAL GENERAL MEETING. Thursday 30 March 2017 at am. H. Lundbeck A/S, Ottiliavej 9, DK-2500 Valby
TO THE SHAREHOLDERS OF H. LUNDBECK A/S NOTICE OF ANNUAL GENERAL MEETING Notice is hereby given of the annual general meeting of H. Lundbeck A/S to be held on: Thursday 30 March 2017 at 10.00 am The general
More informationAssociate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive
Job Title Alliance Lead Analytics Specialist Associate Director Associate Director Diagnostics Partnering Associate Director Business Development Associate Director Application Architecture Associate Manager
More informationNOTICE OF ANNUAL GENERAL MEETING
NOTICE OF ANNUAL GENERAL MEETING Notice is hereby given of the annual general meeting of H. Lundbeck A/S to be held on: Wednesday 25 March 2015 at 10.00 am The general meeting will be held at the offices
More informationBaxter 2007 Investor Conference March 14, 2007
Joy A. Amundson is a corporate vice president of Baxter Healthcare Corporation and president of the company s BioScience business. In this position, she is responsible for the development and worldwide
More informationTom Kähler. Schedule 2. Candidates for the Board of Directors. Chairman Born 11 June 1943 Nationality: Danish
Schedule 2 Candidates for the Board of Directors Tom Kähler Chairman Born 11 June 1943 1971: Graduate Diploma in Business Administration (HD), Copenhagen Business School 1968: MSc (Engineering) (chemistry),
More informationBiotech Concerto #6 Investment Process December 2008
Biotech Concerto #6 Investment Process December 2008 Index Biotech Investment Characteristics Investment Policy Investment Team Scientific Advisory Board Deal Flow Attrition Rate From Screening to Decision
More informationTHE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) Feedback from 93 Eastern-European patient groups PUBLISHED JULY 2016 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID
More informationWhat we do - from blue sky thinking to raw data
Company Profile Who we are Pugatch Consilium is a boutique consultancy firm. We provide evidence-based research, analysis and intelligence on the fastest growing sectors of the knowledge economy. Dynamic
More informationItem 14. Particulars on proposed Directors at Skandinaviska Enskilda Banken AB (publ) s Annual General Meeting on 28 March 2017
Item 14 Particulars on proposed Directors at Skandinaviska Enskilda Banken AB (publ) s Annual General Meeting on 28 March 2017 Re-election of: Johan H. Andresen Born 1961. B.A. (Government and Policy Studies)
More informationItem 14. Particulars on proposed Directors at Skandinaviska Enskilda Banken AB (publ) s Annual General Meeting on 26 March 2018
Item 14 Particulars on proposed Directors at Skandinaviska Enskilda Banken AB (publ) s Annual General Meeting on 26 March 2018 Re-election of: Johan H. Andresen Born 1961. B.A. (Government and Policy Studies)
More informationBOARD OF DIRECTORS. PETER WEHRLY Chair
BOARD OF DIRECTORS PETER WEHRLY Chair Peter Wehrly is the former group president of developed markets at Covidien, the manufacturer of medical devices with sales of over $10.7 billion (2014). Peter held
More informationManagement Team. Bruce C. Cozadd Chairman and Chief Executive Officer
Bruce C. Cozadd Chairman and Chief Executive Officer Bruce Cozadd joined Jazz Pharmaceuticals at its inception and was appointed Jazz Pharmaceuticals Chief Executive Officer in April 2009. From 2003 until
More informationBREAKTHROUGH CONVENTION SUMMARY JUNE SAN DIEGO CONVENTION.BIO.ORG #BIO2017
BREAKTHROUGH CONVENTION SUMMARY JUNE 19-22 SAN DIEGO CONVENTION.BIO.ORG #BIO BIO BY THE NUMBERS FEATURING SEVERAL THEMATIC EXHIBITS 16,123 ATTENDEES 74 48 COUNTRIES STATES 18,000 MORE THAN EXHIBITORS 41,400
More informationSZF Associates. SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry.
SZF Associates Company Mission SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry. We work with strategic and tactical decision
More informationSanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020
PRESS RELEASE Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020 Paris, France May 23, 2016 - Sanofi Chief Executive Officer Olivier Brandicourt, MD, announced today
More informationReinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D
Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D John C. Lechleiter, Ph.D. Chairman, President, and Chief Executive Officer Eli Lilly and Company Washington Biotechnology &
More informationPrevious Attendees List:
Previous Attendees List: Company 3M Abbott Abbott Point of Care Abbott Vascular ACIST Medical ACIST Medical Systems Adamas Pharmaceuticals Aileron Holdings Allergan Allergan Allergan Ansell Healthcare
More informationClinical Forum Attendee Sample Job Titles
Account Executive Account Manager Account Manager, New Sales Development - Europe Advisor, Global Medical Channels and ecapabilities Area Sales Director Assistant Director.Assistant Director Pharm. Tr.
More informationInformation about Members of the Board of Directors proposed by the Nomination Committee of Investor AB 2010
Information about Members of the Board of s proposed by the Nomination Committee of Investor AB 2010 Chairman since 2005 Vice Chairman 1999-2005 since 1998 Vice Chairman: Atlas Copco AB, SAS AB and SEB
More informationKoen Dejonckheere. Professional experience. Board Memberships. Education
Koen Dejonckheere Professional experience KBC SECURITIES GROUP 2002-2008 Managing Director, responsible for Corporate Finance Previously, Koen Dejonckheere was active in Corporate Finance and Private Equity
More informationMethod of Declaration. Hospitality/Interest/Sponsorship
Hospitality/Interest/Sponsorship Date Received Method of Declaration Abbott Laboratories Limited 23/03/12 Sponsorship Abbott Laboratories Limited 28/05/12 Sponsorship Abbott Laboratories Limited 23/03/12
More informationPOST EVENT REPORT IP Life Sciences Exchange 2015
POST EVENT REPORT IP Life Sciences Exchange 2015 A vivid cross-section of present IP challenges, interwoven with opportunities to discuss present needs with solution providers. Deputy Head of IP Egis Pharmaceuticals
More informationTRANSLATIONAL SCIENCE
TRANSLATIONAL SCIENCE A Discussion of Best Practices and Unique Models Wednesday January 31, 2018 at The NYSCF Research Institute HRA TRI-STATE REGIONAL MEETING 31 Wednesday January, 2018 AGENDA 8:30 AM
More informationLife Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack
C5 Business Information in a Global Context Life Sciences CONFERENCE SERIES LIFE SCIENCES IP PORTFOLIO Business Development Pack C5 GROUPS LIFE SCIENCES EVENTS Pharmaceuticals, biotechnology, diagnostics,
More informationCareer Forum Profile. Mr. Clement Chan Managing Director, BDO Limited & President, Hong Kong Institute of CPAs
Mr. Clement Chan is the President of the Hong Kong Institute of Certified Public Accountants. He has actively participated in standards setting and governance activities both in Hong Kong and at international
More informationANNUAL GENERAL MEETING OF SHAREHOLDERS AFFIMED N.V.
ANNUAL GENERAL MEETING OF SHAREHOLDERS AFFIMED N.V. to be held on Tuesday, June 19, 2018 at 15:00 hrs. (CET) at Amsterdam Marriott Hotel, Stadhouderskade 12, 1054 ES Amsterdam, the Netherlands Agenda 1
More informationPlease complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2015 Name: Patrick Pun, MD Title: Asasistant Professor of Medicine Address: DCRI Please complete the applicable rows in the following table. Monetary
More informationSeptember 27, 2016, Priora Business Center, Kloten Zurich Airport / Switzerland
September 27, 2016, Priora Business Center, Kloten Zurich Airport / Switzerland Opportunities and Challenges for Medical Devices companies expanding to Asia Third Cicor Innovation Insights Symposium Supported
More informationPharma-Bio-Med 2006 Conference & Exposition Detailed Programme
Pharma-Bio-Med 2006 Conference & Exposition Detailed Programme November 12-15, 2006 Optional Workshops Nov. 12 & Nov. 16 Lisbon, Portugal The table below provides the Detailed Programme for the Pharma-Bio-Med
More informationElections to the Board of Directors
Elections to the Board of Directors CV of Mr Hugh Scott-Barrett Hugh Scott-Barrett has been a member of the Board of Directors of GAM Holding AG since 2009 and was appointed chairman of the Board of Directors
More informationNOTICE OF ANNUAL GENERAL MEETING. Notice is hereby given of the Annual General Meeting of H. Lundbeck A/S to be held on:
TO THE SHAREHOLDERS OF H. LUNDBECK A/S NOTICE OF ANNUAL GENERAL MEETING Notice is hereby given of the Annual General Meeting of H. Lundbeck A/S to be held on: Thursday, 21 March 2013 at 10:00 AM The Annual
More informationCANDIDATES FOR ELECTION TO THE 2018 COUNCIL
Dr Eva YW Chan FCIS FCS(PE), FCPA, FCCA, MBA, DBA Dr Chan is the Head of Investor Relations of C C Land Holdings Limited (stock code: 1224). With more than 25 years experience as CFO and company secretary
More informationPANEL DISCUSSION & ROUNDTABLES
LIFE SCIENCES & HEALTH CARE EVENT Road to commercialization - Challenges, Opportunities & Successes that lie ahead in the Life Sciences and Healthcare Sectors Life Sciences and Healthcare is one of the
More informationRICHARD BUTLAND Director
RICHARD BUTLAND Richard Butland is the managing partner of Kite Capital, a growth oriented private investment firm. Prior to establishing Kite Capital, Richard spent 15 years at Goldman Sachs where he
More informationTecan Group. Corporate Update CONFERENCE CALL JANUARY 15, 2019
Tecan Group Corporate Update CONFERENCE CALL JANUARY 15, 2019 Speakers Dr Lukas Braunschweiler Chairman Dr David Martyr CEO Dr Achim von Leoprechting EVP 2 CEO Succession Tecan just finished another very
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
More informationItem 14. Particulars on proposed Directors of the Board of Skandinaviska Enskilda Banken AB at the Annual General Meeting on 26 March 2019
Item 14 Particulars on proposed Directors of the Board of Skandinaviska Enskilda Banken AB at the Annual General Meeting on 26 March 2019 Re-election of: Johan H. Andresen Born 1961. B.A. (Government and
More informationAB Electrolux Nomination Committee s proposal for election of the Board of Directors at the Annual General Meeting April 5, 2018
Appendix 7 Non-official translation AB Electrolux Nomination Committee s proposal for election of the Board of Directors at the Annual General Meeting April 5, 2018 Determination of number of Board Members
More informationNOTICE OF ANNUAL GENERAL MEETING. Thursday 31 March 2016 at am. H. Lundbeck A/S, Ottiliavej 9, DK-2500 Valby
TO THE SHAREHOLDERS OF H. LUNDBECK A/S NOTICE OF ANNUAL GENERAL MEETING Notice is hereby given of the annual general meeting of H. Lundbeck A/S to be held on: Thursday 31 March 2016 at 10.00 am The general
More informationProposed for re-election
Appendix 6 Non-official translation AB Electrolux Nomination Committee s proposal for election of the Board of Directors at the Annual General Meeting March 26, 2015 Determination of number of Board Members
More informationWelcome. There s no more exciting time, and no more exciting place, to put your talents to work.
Welcome There s no more exciting time, and no more exciting place, to put your talents to work. My life before McKinsey Born in Lausanne Exchange at the University of Birmingham PhD in Group Theory at
More informationADDRESSING THE DIVERSE HEALTH AND WELL-BEING CHALLENGES OF WOMEN AROUND THE WORLD 22 FEBRUARY 2016
ADDRESSING THE DIVERSE HEALTH AND WELL-BEING CHALLENGES OF WOMEN AROUND THE WORLD 22 FEBRUARY 2016 Welcome Dear all, I am delighted to welcome you to Merck Consumer Health s first Global Consumer Health
More informationLehigh University Team biographies. October 30, 2017
Lehigh University Team biographies October 30, 2017 Core team members 2 Lane McBride Partner and Managing Director, Washington, DC Lane McBride is a Partner and Managing Director in the Washington, D.C.
More informationMANAGING DIRECTOR 360 MADISON AVENUE NEW YORK, NY
Matthew Goldreich MANAGING DIRECTOR MGOLDREICH@CAINBROTHERS.COM 360 MADISON AVENUE NEW YORK, NY 10017 212.981.6946 Matt joined Cain Brothers in 1995 and is one of the longest tenured bankers at the firm.
More informationNVESTOR. 1,400+ Attendees. 2,700+ Partnering Meetings. 768 Companies. 700 Registered Investors. 158 Company Presentations
February 11-12, 2019 New York Marriott Marquis Now in its 21 st year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and
More informationMr. Smith Chairman, President, and Chief Executive Officer Southern Bank
Mr. Smith has been chairman, president, and chief executive officer of Southern Bank since 1992. Mr. Smith has 38 years of banking experience and served as president of Alabama Bank from 1980 to 1991.
More informationCandidates for Supervisory Board submitted by Shareholder CITIBANK OVERSEAS INVESTMENT CORPORATION
Candidates for Supervisory Board submitted by Shareholder CITIBANK OVERSEAS INVESTMENT CORPORATION MR. FRANK MANNION INFORMATION ABOUT THE CANDIDATE 1. Education Mr. Frank Mannion has a Commerce Degree
More informationBOARD OF DIRECTORS. 6. dato mohammed bin haji Che hussein Independent Director (with effect from 1 January 2009) 10. mr olivier lim Tse ghow Director
1. mr richard e. hale Chairman 2. mr liew mun leong Deputy Chairman 3. ms lynette leong Chin yee Chief Executive Officer 4. mr ho Swee huat Independent 5. mr fong Kwok jen Independent 6. dato mohammed
More informationResearch Brief. Clinicians and life sciences companies working together: What types of relationships do clinicians find most appealing?
Research Brief Clinicians and life sciences companies working together: What types of relationships do Truven Health Analytics was acquired by IBM in 2016 to help form a new business, Watson Health. Watson
More informationThe Assessment of Benefits and Harms and Their Relative Importance for Patients, Industry and Agencies: How should they be captured?
The Assessment of Benefits and Harms and Their Relative Importance for Patients, Industry and Agencies: How should they be captured? 2-3 April 2014 PROGRAMME Woodlands Park Hotel, Cobham, Surrey, UK CENTRE
More informationRichard J. Donoghue Senior Vice President for Strategy, Planning and Business Development
Richard J. Donoghue Senior Vice President for Strategy, Planning and Business Development Richard (Rick) J. Donoghue, senior vice president for strategy, planning and business development at NYU Langone
More informationInvitation to the Extraordinary General Meeting of UBS AG
Invitation to the Extraordinary General Meeting of UBS AG Thursday, 2 October 2008, 10:30 a.m. (Doors open at 9:30 a.m.) St. Jakobshalle Brüglingerstrasse 21, Basel Status Report of the Board of Directors
More informationBiographies of the Board Nominees at Adecco s AGM of 29 th June, 2004
Biographies of the Board Nominees at Adecco s AGM of 29 th June, 2004 Dr. Jakob Baer (1944) Swiss nationality Graduated Dr.iur. University of Berne. Began his career at the Swiss Ministry of Finance (1971
More informationPROFILES DIRECTORS. COLIN TAYLOR Non-Executive Director and Chairman. MARK VAN BEUNINGEN Executive Director and Group CEO
DIRECTORS 14 DIRECTORS Colin Taylor Holds an MSc in Management from Imperial College, London and a BSc (Hons) in Engineering with Business Studies from Portsmouth Polytechnic. COLIN TAYLOR Non-Executive
More informationBy-Elections to the Supervisory Board Information about the proposed candidates:
Information on Item 5 of the Agenda By-Elections to the Supervisory Board Information about the proposed candidates: Franz Fehrenbach, Stuttgart, Chairman of the Board of Management of Robert Bosch GmbH
More informationRaymond A. Snead, Jr., D. Sc., FHFMA, FACHE
Doctor of Healthcare Administration and currently practicing CFO whose thirty-five-year career includes serving as the President, Executive Vice President and Chief Financial Officer of for profit and
More informationJochen Danninger CURRICULUM VITAE OF THE CANDIDATES. Born 1975 Nationality: Austrian. Education Master of Laws, University of Vienna
Jochen Danninger Born 1975 Linse2.at 2000 Master of Laws, University of Vienna Since 2017 Managing Director, ecoplus. The Business Agency of Lower Austria 2015 2017 Division Manager, Hypo Niederösterreich
More informationConflict of Interest Statements for The American Journal of Clinical Nutrition Editors
Conflict of Interest Statements for The American Journal of Clinical Nutrition Editors David B Allison Dr. Allison has received personal payments or promises for same from: American Society for Nutrition;
More informationInternational Strategy Development Training: a personal strategic development workshop for Life Sciences Executives of SMEs
International Strategy Development Training: a personal strategic development workshop for Life Sciences Executives of SMEs Do you want to strengthen your business plan for your company?, or refresh your
More informationBinding recommendations
Members of the Board of Management Members of the Supervisory Board In relation to the General Meeting of Shareholders of Koninklijke Philips Electronics N.V. ( Royal Philips Electronics ) To be held on
More informationRehab Group Board Members Appointed 8 September 2014
Rehab Group Board Members Appointed 8 September 2014 Seán Egan is a London-born PhD graduate of Trinity College, Dublin who commenced his business career with BT and worked in a variety of roles in the
More information(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K
DCRI Commercial relationships Tracking Form Year: 2018 Name: Adrian Hernandez, M.D. Title: Vice Dean, Clinical, School of Medicine Address: 200 Trent Dr., Durham NC 27710 Please complete the applicable
More informationColonial Mutual Superannuation Pty Ltd ABN
Colonial Mutual Superannuation Pty Ltd ABN 56 006 831 983 Executive Officers CMSExecutiveOfficersandTrustees_20160627 Ms Anne Ward Anne Ward is a professional company director with experience in business
More informationLaunch of new transatlantic specialty pharma company
For immediate release Thursday 1 March 2007 EUSA Pharma Inc ( EUSA Pharma or the Company ) Launch of new transatlantic specialty pharma company EUSA Pharma raises $175m for both the acquisition of OPi
More informationCelebrating International Women's Day Friday, March 8, :30am-1:00pm
Co-Hosted by: Join us in Launching the 1st Annual Successful Women of San Diego Executive Leadership Panel Celebrating International Women's Day Friday, March 8, 2019 11:30am-1:00pm Sponsored by: Location:
More informationDirectors and Senior Management
Directors and Senior Management Victor FUNG Kwok King Group Non-Executive Chairman Victor FUNG Kwok King, aged 56, brother of Dr William FUNG Kwok Lun, is Group Chairman. He joined the Group in 1973 as
More informationIgor Fisch. New candidate, independent
Igor Fisch New candidate, independent Igor Fisch is a co-founder of Selexis SA, a biotech company based in Switzerland. He grew the company from inception to profits in less than 5 years with up to > 5MCHF
More informationInformation regarding proposed persons: Stanley Brodén. Proposed for re-election as Director and Chairman of the Board. Year of birth 1951
Information regarding proposed persons: Stanley Brodén Proposed for re-election as Director and Chairman of the Year of birth 1951 Economic studies at Linköping University. MiL s Management training. Extensive
More informationInformation about members of the Board of Directors proposed by the Nomination Committee of Investor AB 2007
Information about members of the Board of s proposed by the Nomination Committee of Investor AB 2007 Chairman since 2005 Vice Chairman since 1999 since 1998 Vice Chairman: Atlas Copco AB, SAS AB and SEB
More informationBiographical Details of Directors & Senior Management
The biographical details of directors and senior management are set out as follows: Board of Directors Executive Directors Mr. Anthony Siu Wing LAU (Executive Chairman) Aged 65, is a founder, chairman
More informationSupervisory Board of Deutsche Börse Aktiengesellschaft 2018
www.deutsche-boerse.com Election of members of the new Supervisory Board of Deutsche Börse Aktiengesellschaft 2018 Proposal for the election of Supervisory Board members representing the shareholders Proposal
More informationThe European Association of Consultants to and about Not-For-Profit Organisations
The European Association of Consultants to and about Not-For-Profit Organisations EUCONSULT SPRING WORKSHOP 23-24 MARCH 2017 SPEAKER/FACILITATOR PROFILES Daniel Ambrus Head of Communications, Networks
More informationExclusive. InterContinental Shanghai, Expo Pudong New District, Shanghai Thursday October 27, 2016
InterContinental Shanghai, Expo Pudong New District, Shanghai Thursday October 27, 2016 Exclusive Asia Cicor Innovation Insights Symposium Opportunities and Challenges for Medical Devices companies Asia
More informationTHE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES
THE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES Join us for a very special program co-hosted the HBS Alumni of Boston (HBSAB), The Harvard Stem Cell Institute (HSCI), and the Harvard NeuroDiscovery
More informationDr. Eberhard Bessey. Daimler AG Group Research and Advanced Engineering (GR&AE)
Dr. Eberhard Bessey Daimler AG Group Research and Advanced Engineering (GR&AE) Group Research Product Innovations and Process Technologies - Materials Manufacturing Concepts (GR/PM) Senior Manager Technology
More informationThe audience hall or council chamber was where a council of ministers and advisors would gather to discuss administration and operations.
The audience hall or council chamber was where a council of ministers and advisors would gather to discuss administration and operations. Var. ri. ga Sa. baa. va The Board of Directors Introductory Statements
More informationDealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved.
Dealdoc Acquisition agreement for Gambro Baxter International Gambro Dec 04 2012 Acquisition agreement for Gambro Companies: Baxter International Gambro Announcement date: Dec 04 2012 Deal value, US$m:
More informationVantiv, now Worldpay Investor Relations
Vantiv, now Worldpay Investor Relations Connecting to financial markets Conversing with investors and shareholders Executive Officers Charles Drucker Executive Chairman and Co-Chief Executive Officer Charles
More informationNotice of Annual General Meeting Notice is hereby given of the Annual General Meeting of H. Lundbeck A/S to be held on:
H. Lundbeck A/S Ottiliavej 9 Tel +45 36 30 13 11 E-mail investor@lundbeck.com DK-2500 Valby, Copenhagen Fax +45 36 43 82 62 www.lundbeck.com CVR number: 56759913 Corporate Release No 430 7 March 2011 Notice
More informationCANADIAN LEADERSHIP TASKFORCE ON INDUSTRY GROWTH
CANADIAN LEADERSHIP TASKFORCE ON INDUSTRY GROWTH 2016 2017 Meet our leaders: Kim Allen is the chief executive officer of Engineers Canada, the national organization of organizations that regulate Canada
More informationEngr. VIRGINIA F. AUMENTADO Patent Information Analytics and Technology Monitoring Division (PATMD)
13% 13% 74% Engr. VIRGINIA F. AUMENTADO Patent Information Analytics and Technology Monitoring Division (PATMD) Introduction on IPOPhl s Patent System Innovation Support Strategies TOPICS Patent Mapping/Analytics
More informationOmeros Raises More Than $63 Million in Financing
Omeros Raises More Than $63 Million in Financing Seattle, WA February 12, 2007 Omeros today announced that it has raised in excess of $63 million in an oversubscribed Series E equity financing. New investors,
More informationInternational Presence, Local Expertise. Introductory Presentation
International Presence, Local Expertise Introductory Presentation About GlobalM&A Partners Established in 1999 A partnership of 38 leading independent M&A firms Over 200 active dealmakers supported by
More informationComprehensive Research Services
Comprehensive Research Services Scripps Health: At the Forefront of Clinical Research Scripps Health is a recognized leader in clinical research and has long been at the forefront of numerous medical breakthroughs.
More informationBrad Nelson Dr. Ulla Grauschopf
Plenary Session Brad Nelson is the Professor of Robotics and Intelligent Systems at ETH Zürich. His primary research focus is on microrobotics and nanorobotics emphasizing applications in biology and medicine.
More informationViking Advisory Group. Company Presentation September 2011
Viking Advisory Group Company Presentation September 2011 Viking Advisory Group Mission To offer value added, high quality services within the disciplines of financial management, accounting, legal, insurance,
More informationTo the shareholders of Nordic Nanovector ASA Oslo, 8 May 2018
To the shareholders of Nordic Nanovector ASA Oslo, 8 May 2018 RECOMMENDATION OF THE NOMINATION COMMITTEE 1. INTRODUCTION The Nomination Committee of Nordic Nanovector ASA comprises of Johan Christenson
More informationGerresheimer CAPITAL MARKETS DAY 2010
Gerresheimer CAPITAL MARKETS DAY 2010 Gerresheimer Today September 1, 2010 Uwe Röhrhoff, CEO Gerresheimer who we are and what we do Gerresheimer is an important partner of the pharmaceutical and healthcare
More informationCASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc. Your Strategic Drug Development Partner in China NASDAQ: CASI WWW.CASIPHARMACEUTIALS.COM Forward Looking Statements This presentation contains forward-looking statements within
More informationDirectors and Senior Management
Directors and Senior Management Victor FUNG Kwok King Group Non-Executive Chairman Victor FUNG Kwok King, aged 57, brother of Dr William FUNG Kwok Lun, is Group Chairman. He joined the Group in 1973 as
More informationExperiences of an aspiring young scientist-entrepreneur
Experiences of an aspiring young scientist-entrepreneur Francis W. Hunter Auckland Cancer Society Research Centre Spark Entrepreneurship Challenge Mesopharm Therapeutics, Inc. 5 May 2014 Background Auckland
More informationContents About Camp Quality 6 Our Purpose 7 Chairman s Message 8 CEO s Message 10 Highlights What we are excited about 12 2011 2012 Strategic Focus 13 Our Programs 14 17 Our Supporters 18 23 Our People
More informationMedTech Alliance Program Spring Meeting
Oregon Health & Science University Presents: MedTech Alliance Program Spring Meeting OHSU will be hosting its second MedTech Alliance program meeting on Wednesday, May 6 from 5:00PM to 7:30PM. Community
More informationLehrkräfte in der CRRA- Ausbildung
Lehrkräfte in der CRRA- Ausbildung Dr. Ferdinand Hund The Program Director of the certificate program in Clinical Research and Regulatory Affairs at the Health Department of the DUW Institut für Weiterbildung
More informationPlease complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2016 Name: Shelby D. Reed, PhD Title: Professor Address: PO Box 17969, Durham, NC 27715 Please complete the applicable rows in the following table.
More informationImplementation of a new SCOR Executive Committee and a new SCOR Switzerland Executive Committee
(p.1/6) For further information, please contact: Godefroy de Colombe +33 (0)1 46 98 73 50 Director for Public Affairs Jim Root +33 (0)1 46 98 72 32 Director for Investor Relations Implementation of a new
More information